A company called BioViva is getting calls from athletes, trainers, and coaches looking to use one of its gene therapies, says New Scientist. The company claims the experimental therapy blocks the breakdown of muscle tissue, which would be useful for athletes looking for more efficient ways to build muscle or keep their muscles from breaking down. And even though there's no clear evidence yet that the therapy does what it's supposed to do, the athletes keep calling.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.